A Pilot Study of Celecoxib in Patients With Grade 2 or 3 Uterine Cancers

This study has been terminated.
(Due to reported toxicity of Celecoxib at high doses)
Sponsor:
Collaborator:
Pharmacia
Information provided by (Responsible Party):
Mark H. Einstein, Montefiore Medical Center
ClinicalTrials.gov Identifier:
NCT00231829
First received: September 30, 2005
Last updated: April 22, 2012
Last verified: April 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: March 2004
  Primary Completion Date: March 2004 (Final data collection date for primary outcome measure)